Appointed
Jordan N. Freeman
Chief Accounting Officer
NRC ·
NRC HEALTH
appointed Jordan N. Freeman as the Company’s Chief Accounting Officer.
Ready 8-Ks
21
Latest filing
April 28, 2026, 7:59 PM ET
Top materiality
0.75
Event mix
earnings ×9 · leadership ×6 · other_material ×3
Sentiment
4 pos · 2 neg · 15 neu
Latest earnings
reported 2026-Q1
Executive change
recent →
Recent 8-K filings for NRC
Highest-materiality recent filing
NRC Health Q1 revenue up 4% to $34.8M; TRCV record $152.1M (+13% YoY)
- GAAP net income $3.2M ($0.14 diluted EPS); adjusted net income $4.6M ($0.21 adjusted diluted EPS).
- Adjusted EBITDA $9.4M (27% of revenue); cash flow from operations $7.2M up 8% YoY.
-
NRC Health Q1 revenue up 4% to $34.8M; TRCV record $152.1M (+13% YoY)
GAAP net income $3.2M ($0.14 diluted EPS); adjusted net income $4.6M ($0.21 adjusted diluted EPS).
-
NRC Health amends exec stock awards, eliminates repurchase right; expects $9.4M Q2 expense
Committee amended grants to CEO Trent Green (500k shares), COO Helen Hrdy (100k), and Chief Corp Dev Officer Andrew Monich (100k) to eliminate repurchase right.
-
NRC Health TRCV reaches all-time high of $152M, up 13% YoY
TRCV surpassed $152 million as of March 4, 2026, a new all-time high for NRC Health.
-
NRC Health Q3 2025: TRCV up 8% to $141.7M; Adj EBITDA +11% YoY to $10.9M
Revenue $34.6M (+2% QoQ); GAAP net income $4.1M (12% of revenue); Adj net income $5.0M (14% of revenue).
-
NRC Health names Shane Harrison CFO effective Sept 25, 2025
Shane Harrison appointed Executive VP and CFO, succeeding Michael D. Hays as principal financial officer.
-
National Research Corporation Reports Q1 2025 Results and Announces Share Repurchase Program
Total recurring value contract value increased sequentially for second consecutive quarter.
-
NRC appoints Trent Green as CEO effective June 1, 2025; Hays becomes Chairman
Trent Green named CEO effective June 1, 2025; current CEO Mike Hays transitions to Chairman.
-
NRC Q4 revenue $36.9M, EPS $0.28; CTO Louvion resigns
Q4 revenue $36.9M vs $38.0M YoY; diluted EPS $0.28 vs $0.36.
-
National Research CFO/PAO Linda Stacy to retire effective Dec 31, 2024
Linda Stacy notified company of retirement as Secretary, Principal Financial Officer, and Principal Accounting Officer.
-
NRC Health Q3 revenue falls 5.5% to $35.8M; EPS drops to $0.24 from $0.32
Revenue $35.8M vs $37.9M a year ago; diluted EPS $0.24 vs $0.32.
-
NRC Health Q2 revenue $35M, EPS $0.26; amends credit; acquires NOBL Health
Q2 revenue ~$35M vs ~$36M YoY; diluted EPS $0.26 vs $0.29 YoY; TRCV $138M at June 30.
Executive changes
Role change
(interim)
Michael D. Hays
principal financial officer
NRC ·
NRC HEALTH
designated Michael D. Hays, the Company’s Chief Executive Officer, to serve as the Company’s principal financial officer.
Appointed
Trent Green
Chief Executive Officer
NRC ·
NRC HEALTH
the board of directors of National Research Corporation, a Delaware corporation (the “Company”) appointed Trent Green as our Chief Executive Officer and to serve as a director, both effective June 1, 2025.
Appointed
(interim)
Linda Stacy
Interim Principal Financial Officer
NRC ·
NRC HEALTH
the Board appointed Linda Stacy to serve as Interim Principal Financial Officer until March 31, 2025
Role change
Micheal D. Hays
Chairman
NRC ·
NRC HEALTH
Micheal D. Hays, the Company’s current Chief Executive Officer, will transition to the role of Chairman
Appointed
Trent Green
Chief Executive Officer
NRC ·
NRC HEALTH
the Board appointed Trent Green as the Company’s Chief Executive Officer and to serve as a director, both effective June 1, 2025
Departed
Linda Stacy
Secretary, Principal Financial Officer, and Principal Accounting Officer
NRC ·
NRC HEALTH
On November 8, 2024, Linda Stacy, Secretary, Principal Financial Officer, and Principal Accounting Officer of National Research Corporation (the “Company”), notified the Company of her decision to retire effective December 31, 2024.
Appointed
Helen L. Hrdy
Chief Operating Officer
NRC ·
NRC HEALTH
On October 14, 2024, the Board of Directors of National Research Corporation, a Delaware corporation (the "Company"), appointed Helen L. Hrdy as the Company’s Chief Operating Officer.
Role change
Linda Stacy
Principal Financial Officer
NRC ·
NRC HEALTH
On May 7, 2024, the Company’s Board of Directors appointed Linda Stacy as the Company’s Principal Financial Officer.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.75 · Median 0.60 · Most common event earnings